BA
ABBV icon

Ballast Advisors’s AbbVie ABBV Stock Holding History

Ballast Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$465K Sell
2,139
-23
-1% -$5.1K 0.14% 73
2025
Q4 		$494K Sell
2,162
-116
-5% -$26.4K 0.14% 71
2025
Q3 		$528K Sell
2,278
-149
-6% -$30.3K 0.15% 70
2025
Q2 		$451K Buy
2,427
+69
+3% +$12.8K 0.13% 76
2025
Q1 		$494K Sell
2,358
-316
-12% -$61.4K 0.16% 71
2024
Q4 		$475K Buy
2,674
+137
+5% +$25.2K 0.15% 73
2024
Q3 		$501K Sell
2,537
-184
-7% -$34.3K 0.15% 71
2024
Q2 		$467K Buy
2,721
+171
+7% +$28.3K 0.15% 73
2024
Q1 		$464K Sell
2,550
-169
-6% -$29.1K 0.16% 74
2023
Q4 		$421K Buy
2,719
+2
+0.1% +$292 0.16% 77
2023
Q3 		$405K Sell
2,717
-83
-3% -$12.2K 0.16% 79
2023
Q2 		$377K Sell
2,800
-72
-3% -$10.6K 0.14% 78
2023
Q1 		$458K Buy
2,872
+74
+3% +$11.3K 0.18% 58
2022
Q4 		$452K Sell
2,798
-43
-2% -$6.59K 0.2% 57
2022
Q3 		$381K Sell
2,841
-23
-0.8% -$3.3K 0.18% 62
2022
Q2 		$439K Buy
2,864
+25
+0.9% +$3.82K 0.2% 61
2022
Q1 		$460K Buy
2,839
+1
+0% +$145 0.18% 66
2021
Q4 		$384K Buy
2,838
+1
+0% +$118 0.15% 76
2021
Q3 		$306K Buy
2,837
+2
+0.1% +$229 0.13% 86
2021
Q2 		$319K Sell
2,835
-284
-9% -$32K 0.13% 79
2021
Q1 		$338K Buy
3,119
+191
+7% +$20.4K 0.16% 72
2020
Q4 		$314K Buy
2,928
+2
+0.1% +$192 0.16% 74
2020
Q3 		$256K Buy
2,926
+1
+0% +$94 0.16% 77
2020
Q2 		$287K Buy
+2,925
New +$258K 0.2% 67
2020
Q1 		– Sell
-2,616
Closed -$232K – 155
2019
Q4 		$232K Buy
+2,616
New +$217K 0.17% 84

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ballast Advisors's ABBV Position: Q1 2026 in Review

Ballast Advisors reduced its AbbVie (ABBV) stake by 1.1% in Q1 2026, selling an estimated $5.1K and leaving 2,139 shares worth $465K. The position accounts for 0.14% of the portfolio, ranked #73.

Ballast Advisors first reported a position in ABBV in Q4 2019 and has held it in 25 quarters since. The position peaked at $528K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Ballast Advisors held 2,139 shares of AbbVie worth $465K as of Q1 2026.
  • Ballast Advisors sold 23 AbbVie shares in Q1 2026, an estimated $5.1K.
  • AbbVie made up 0.14% of Ballast Advisors's portfolio in Q1 2026, its #73 holding.
  • Ballast Advisors first reported a position in AbbVie in Q4 2019 and has held it in 25 quarters since.
  • Ballast Advisors's AbbVie position peaked at $528K in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Ballast Advisors's 13F filing for Q1 2026, filed 13 May 2026.